Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MIF | P14174 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22036029 | 0.94 | MIF (0.37) | MIFMEN1ALDH1A1MAPTALOX15 | |
| SCHEMBL25822175 | 0.85 | MIF (0.32) | MIF | |
| SCHEMBL4757626 | 0.84 | MIF (0.40) | MIFMEN1ALDH1A1MAPTALOX15 | |
| SCHEMBL7694728 | 0.80 | MIF (0.39) | MIFMEN1ALDH1A1MAPTALOX15 | |
| SCHEMBL13265129 | 0.80 | MIF (0.39) | MIFMEN1ALDH1A1MAPTALOX15 | |
| SCHEMBL25988750 | 0.79 | MIF (0.38) | MIFMEN1ALDH1A1MAPTALOX15 | |
| SCHEMBL4755288 | 0.76 | MIF (0.42) | MIFMEN1ALDH1A1MAPTALOX15 | |
| SCHEMBL12251472 | 0.73 | MIF (0.40) | MIFMEN1ALDH1A1MAPTALOX15 | |
| SCHEMBL13649840 | 0.73 | MIF (0.40) | MIFMEN1ALDH1A1MAPTALOX15 | |
| SCHEMBL472121 | 0.73 | MAPT (0.44) | MIFMEN1ALDH1A1MAPTALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7981951-B2 | Process for producing epoxides from olefinic compounds | DOW GLOBAL TECHNOLOGIES LLC | 2011-07-19 | — | — | US | disclosed |
| US-7981951-B2 | Process for producing epoxides from olefinic compounds | DOW GLOBAL TECHNOLOGIES LLC | 2011-07-19 | — | — | US | disclosed |
| US-20100029848-A1 | PROCESS FOR PRODUCING EPOXIDES FROM OLEFINIC COMPOUNDS | BLUE CUBE IP LLC | 2010-02-04 | — | — | US | disclosed |
| US-20100029848-A1 | PROCESS FOR PRODUCING EPOXIDES FROM OLEFINIC COMPOUNDS | BLUE CUBE IP LLC | 2010-02-04 | — | — | US | disclosed |
| WO-2008002416-A1 | PROCESS FOR PRODUCING EPOXIDES FROM OLEFINIC COMPOUNDS | DOW GLOBAL TECHNOLOGIES INC. (US) | 2008-01-03 | — | — | WO | disclosed |
| US-6201070-B1 | PROTECTIVE COATINGS WITH CYCLOHEXYLEPOXIDECARBOXYLIC ESTERS | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION | 2001-03-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100029848-A1 | PROCESS FOR PRODUCING EPOXIDES FROM OLEFINIC COMPOUNDS | SQLE, PPOX, DUOX1 | MIF 4582/4885MEN1 3609/4885ALDH1A1 587/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.